Publications
156 results found
Ancona MB, Giannini F, Mangieri A, et al., 2017, Impact of Mitral Annular Calcium on Outcomes after Transcatheter Aortic Valve Implantation, AMERICAN JOURNAL OF CARDIOLOGY, Vol: 120, Pages: 2233-2240, ISSN: 0002-9149
- Author Web Link
- Cite
- Citations: 21
Naganuma T, Kawamoto H, Panoulas VF, et al., 2017, Mid-term clinical outcomes of ABSORB bioresorbable vascular scaffold versus everolimus-eluting stent for coronary bifurcation lesions, INTERNATIONAL JOURNAL OF CARDIOLOGY, Vol: 246, Pages: 26-31, ISSN: 0167-5273
- Author Web Link
- Cite
- Citations: 7
Cathcart L, El-Jahel L, Jabbour R, 2017, Basel II: an engine without brakes, Journal of Banking Regulation, Vol: 18, Pages: 359-374, ISSN: 1745-6452
The primary goal sought by the Bank of International Settlements and its committee on banking supervision (BCBS) is to make banks safer entities while maintaining a “level playing field.” However, the question of whether this objective can be attained through enforcing capital requirements is still debatable due to the controversy surrounding the impact of regulatory standards, in particular, the Basel I and II accords on crises that occurred soon after the frameworks were introduced. While the impact of the latter remains controversial in the U.S. due to its effective implementation date, we observe that the newly introduced capital requirements could have played a role in the buildup to the subprime crisis. These results have direct policy implications with regard to ongoing revisions to Basel III, in particular the standardized approach for credit risk.
Jabbour R, Tanaka A, Finkelstein A, et al., 2017, Delayed coronary obstruction after transcatheter aortic valve replacement, 29th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), Publisher: ELSEVIER SCIENCE INC, Pages: B16-B16, ISSN: 0735-1097
- Author Web Link
- Cite
- Citations: 1
Ahmad Y, Demir O, Howard J, et al., 2017, Aspirin is equivalent to dual antiplatelet therapy after transcatheter aortic valve replacement: a meta-analysis of 11,781 patients, 29th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), Publisher: ELSEVIER SCIENCE INC, Pages: B54-B54, ISSN: 0735-1097
Ancona M, Giannini F, Mangieri A, et al., 2017, Impact of Mitral Annular Calcification on Clinical Outcomes after Transcatheter Aortic Valve Implantation, 29th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), Publisher: ELSEVIER SCIENCE INC, Pages: B253-B254, ISSN: 0735-1097
Mangieri A, Lanzillo G, Bertoldi L, et al., 2017, Predictors of advanced conduction disturbances requiring a late (≥48 hours) permanent pacemaker following transcatheter aortic valve implantation, 29th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), Publisher: ELSEVIER SCIENCE INC, Pages: B230-B231, ISSN: 0735-1097
Mitomo S, Jabbour R, Mangieri A, et al., 2017, Comparison of mid-term clinical outcomes after treatment of ostial right coronary artery lesions with early and new generation drug-eluting stents: insights from an international multicenter registry, 29th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), Publisher: ELSEVIER SCIENCE INC, Pages: B313-B314, ISSN: 0735-1097
Lanzillo G, Bertoldi L, Montalto C, et al., 2017, Pacemaker-related complications in patients undergoing transcatheter aortic valve implantation: a single-center experience, 29th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), Publisher: ELSEVIER SCIENCE INC, Pages: B110-B110, ISSN: 0735-1097
Tanaka A, Jabbour R, Adamo M, et al., 2017, Technical safety and feasibility of coronary interventions in patients with prior self-expanding transcatheter aortic valve replacement, 29th Annual Symposium on Transcatheter Cardiovascular Therapeutics (TCT), Publisher: ELSEVIER SCIENCE INC, Pages: B178-B179, ISSN: 0735-1097
Mitomo S, Naganuma T, Jabbour RJ, et al., 2017, Impact of target vessel on long-term cardiac mortality after successful chronic total occlusion percutaneous coronary intervention: Insights from a Japanese multicenter registry, INTERNATIONAL JOURNAL OF CARDIOLOGY, Vol: 245, Pages: 77-82, ISSN: 0167-5273
- Author Web Link
- Cite
- Citations: 11
Chow A, Stuckey DJ, Kidher E, et al., 2017, Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Encapsulating Bioactive Hydrogels Improve Rat Heart Function Post Myocardial Infarction., Stem Cell Reports, Vol: 9, Pages: 1415-1422, ISSN: 2213-6711
Tissue engineering offers an exciting possibility for cardiac repair post myocardial infarction. We assessed the effects of combined polyethylene glycol hydrogel (PEG), human induced pluripotent stem cell-derived cardiomyocyte (iPSC-CM), and erythropoietin (EPO) therapy in a rat model of myocardial infarction. PEG with/out iPSC-CMs and EPO; iPSC-CMs in saline; or saline alone was injected into infarcted hearts shortly after infarction. Injection of almost any combination of the therapeutics limited acute elevations in chamber volumes. After 10 weeks, attenuation of ventricular remodeling was identified in all groups that received PEG injections, while ejection fractions were significantly increased in the gel-EPO, cell, and gel-cell-EPO groups. In all treatment groups, infarct thickness was increased and regions of muscle were identified within the scar. However, no grafted cells were detected. Hence, iPSC-CM-encapsulating bioactive hydrogel therapy can improve cardiac function post myocardial infarction and increase infarct thickness and muscle content despite a lack of sustained donor-cell engraftment.
Jabbour RJ, Frame A, Sen S, et al., 2017, Day case TAVI: is this a reality?, EUROINTERVENTION, Vol: 13, Pages: 907-909, ISSN: 1774-024X
- Author Web Link
- Cite
- Citations: 1
Spartera M, Jabbour RJ, Chiarito M, et al., 2017, Stepwise use of circulatory support devices in a patient refractory to cardiopulmonary resuscitation, CARDIOVASCULAR REVASCULARIZATION MEDICINE, Vol: 18, Pages: 447-449, ISSN: 1553-8389
- Author Web Link
- Cite
- Citations: 8
Giannini F, Montorfano M, Jabbour RJ, et al., 2017, Use of a parallel stiff wire to facilitate percutaneous Impella RP ventricular assist device positioning, CARDIOVASCULAR REVASCULARIZATION MEDICINE, Vol: 18, Pages: S54-S55, ISSN: 1553-8389
- Author Web Link
- Cite
- Citations: 3
Jabbour RJ, Sen S, Mikhail GW, et al., 2017, Out-of-hospital cardiac arrest: Concise review of strategies to improve outcome, CARDIOVASCULAR REVASCULARIZATION MEDICINE, Vol: 18, Pages: 450-455, ISSN: 1553-8389
- Author Web Link
- Cite
- Citations: 7
Ferri LA, Jabbour RJ, Giannini F, et al., 2017, Safety and efficacy of rotational atherectomy for the treatment of undilatable underexpanded stents implanted in calcific lesions, CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol: 90, Pages: E19-E24, ISSN: 1522-1946
- Author Web Link
- Cite
- Citations: 37
Mitomo S, Latib A, Tanaka A, et al., 2017, RESEARCH LETTER: Dual Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation Insights From the Milan Cohort, JACC-CARDIOVASCULAR INTERVENTIONS, Vol: 10, Pages: 1471-1472, ISSN: 1936-8798
- Author Web Link
- Cite
- Citations: 1
Mangieri A, Montalto C, Pagnesi M, et al., 2017, Mechanism and Implications of the Tricuspid Regurgitation From the Pathophysiology to the Current and Future Therapeutic Options, CIRCULATION-CARDIOVASCULAR INTERVENTIONS, Vol: 10, ISSN: 1941-7640
- Author Web Link
- Cite
- Citations: 67
Tanaka A, Jabbour RJ, Giannini F, et al., 2017, Saphenous Vein Graft Aneurysm 10 Years After Paclitaxel-Eluting Stent Implantation, JOURNAL OF INVASIVE CARDIOLOGY, Vol: 29, Pages: E63-E63, ISSN: 1042-3931
Jabbour RJ, Giannini F, Tanaka A, et al., 2017, Advances in percutaneous interventional therapies: the tricuspid valve, FUTURE CARDIOLOGY, Vol: 13, ISSN: 1479-6678
- Author Web Link
- Cite
- Citations: 2
Jabbour RJ, Tanaka A, Capranzano P, et al., 2017, Bioresorbable Vascular Scaffolds as a Treatment Option for Left Main Lesions, JACC-CARDIOVASCULAR INTERVENTIONS, Vol: 10, Pages: 743-745, ISSN: 1936-8798
- Author Web Link
- Cite
- Citations: 2
Tanaka A, Latib A, Jabbour RJ, et al., 2017, Bioresorbable Vascular Scaffolds and Very Late Scaffold Thrombosis Searching an Explanation and a Solution, JACC-CARDIOVASCULAR INTERVENTIONS, Vol: 10, Pages: 745-746, ISSN: 1936-8798
- Author Web Link
- Cite
- Citations: 2
Mangieri A, Jabbour RJ, Montalto C, et al., 2017, Single-Antiplatelet Therapy in Patients with Contraindication to Dual-Antiplatelet Therapy After Transcatheter Aortic Valve Implantation, AMERICAN JOURNAL OF CARDIOLOGY, Vol: 119, Pages: 1088-1093, ISSN: 0002-9149
- Author Web Link
- Cite
- Citations: 36
Del Furia F, Ancona MB, Giannini F, et al., 2017, First-in-man Percutaneous LAA Closure With an Amplatzer Amulet and TriGuard Embolic Protection Device in a Patient With LAA Thrombus, JOURNAL OF INVASIVE CARDIOLOGY, Vol: 29, Pages: E51-E52, ISSN: 1042-3931
- Author Web Link
- Cite
- Citations: 4
Tanaka A, Jabbour RJ, Mitomo S, et al., 2017, Hybrid Percutaneous Coronary Intervention With Bioresorbable Vascular Scaffolds in Combination With Drug-Eluting Stents or Drug-Coated Balloons for Complex Coronary Lesions, JACC-CARDIOVASCULAR INTERVENTIONS, Vol: 10, Pages: 539-547, ISSN: 1936-8798
- Author Web Link
- Cite
- Citations: 9
Beurtheret S, Tutarel O, Diller GP, et al., 2017, Contemporary cardiac surgery for adults with congenital heart disease, Heart, Vol: 103, Pages: 1194-1202, ISSN: 1355-6037
Objective Advances in early management of congenital heart disease (CHD) have led to an exponential growth in adults with CHD (ACHD). Many of these patients require cardiac surgery. This study sought to examine outcome and its predictors for ACHD cardiac surgery.Methods This is an observational cohort study of prospectively collected data on 1090 consecutive adult patients with CHD, undergoing 1130 cardiac operations for CHD at the Royal Brompton Hospital between 2002 and 2011. Early mortality was the primary outcome measure. Midterm to longer-term survival, cumulative incidence of reoperation, other interventions and/or new-onset arrhythmia were secondary outcome measures. Predictors of early/total mortality were identified.Results Age at surgery was 35±15 years, 53% male, 52.3% were in New York Heart Association (NYHA) class I, 37.2% in class II and 10.4% in class III/IV. Early mortality was 1.77% with independent predictors NYHA class ≥ III, tricuspid annular plane systolic excursion (TAPSE) <15 mm and female gender. Over a mean follow-up of 2.8±2.6 years, 46 patients died. Baseline predictors of total mortality were NYHA class ≥ III, TAPSE <15 mm and non-elective surgery. The number of sternotomies was not independently associated with neither early nor total mortality. At 10 years, probability of survival was 94%. NYHA class among survivors was significantly improved, compared with baseline.Conclusions Contemporary cardiac surgery for ACHD performed at a single, tertiary reference centre with a multidisciplinary approach is associated with low mortality and improved functional status. Also, our findings emphasise the point that surgery should not be delayed because of reluctance to reoperate only.
Jabbour RJ, Tanaka A, Mangieri A, et al., 2017, Long-term outcome of full plastic jacket treatment for bare metal in-stent restenosis*, CARDIOVASCULAR REVASCULARIZATION MEDICINE, Vol: 18, Pages: 139-140, ISSN: 1553-8389
- Author Web Link
- Cite
- Citations: 1
Giannini F, Latib A, Jabbour RJ, et al., 2017, The ratio of contrast volume to glomerular filtration rate predicts acute kidney injury and mortality after transcatheter aortic valve implantation, CARDIOVASCULAR REVASCULARIZATION MEDICINE, Vol: 18, Pages: 349-355, ISSN: 1553-8389
- Author Web Link
- Cite
- Citations: 11
Jabbour R, Tanaka A, Capranzano P, et al., 2017, Bioresorbable Vascular Scaffolds As A Treatment Option For Left Main Lesions, Publisher: ELSEVIER SCIENCE INC, Pages: S28-S28, ISSN: 1936-8798
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.